An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity.

Inborn errors of immunity newborn screening next-generation sequencing severe combined immunodeficiency

Journal

The Journal of allergy and clinical immunology
ISSN: 1097-6825
Titre abrégé: J Allergy Clin Immunol
Pays: United States
ID NLM: 1275002

Informations de publication

Date de publication:
02 2021
Historique:
received: 27 10 2020
revised: 18 12 2020
accepted: 18 12 2020
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 14 9 2021
Statut: ppublish

Résumé

Wilson and Jungner's recommendations for population-based screening have been used to guide decisions regarding candidate disease inclusion in newborn screening programs for the past 50 years. The advent of genomic-based technologies, including next-generation sequencing and its potential application to newborn screening, along with a changing landscape in terms of modern clinical practice and ethical, social, and legal considerations has led to a call for review of these criteria. Inborn errors of immunity (IEI) are a heterogeneous group of more than 450 genetically determined disorders of immunity, which are associated with significant morbidity and mortality, particularly where diagnosis and treatment are delayed. We argue that in addition to screening for severe combined immunodeficiency disease, which has already been initiated in several countries, other clinically significant IEI should be screened for at birth. Because of disease heterogeneity and identifiable genetic targets, a next-generation sequencing-based screening approach would be most suitable. A combination of worldwide experience and technological advances has improved our ability to diagnose and effectively treat patients with IEI. Considering IEI in the context of updated recommendations for population-based screening supports their potential inclusion as disease targets in newborn screening programs.

Identifiants

pubmed: 33551024
pii: S0091-6749(20)32422-2
doi: 10.1016/j.jaci.2020.12.633
pmc: PMC8344044
mid: NIHMS1727103
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

428-438

Subventions

Organisme : Intramural NIH HHS
ID : ZIA AI001222
Pays : United States

Informations de copyright

Copyright © 2020 American Academy of Allergy, Asthma & Immunology. All rights reserved.

Références

Blood. 2018 Oct 25;132(17):1737-1749
pubmed: 30154114
N Engl J Med. 2019 Jan 10;380(2):163-170
pubmed: 30625055
Front Immunol. 2019 Nov 06;10:2438
pubmed: 31781088
J Allergy Clin Immunol. 2017 Dec;140(6):1660-1670.e16
pubmed: 28400115
Blood. 2019 Jun 6;133(23):2465-2477
pubmed: 30992265
J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946
pubmed: 29729943
J Clin Immunol. 2020 Nov;40(8):1124-1131
pubmed: 32880085
Mol Ther. 2018 Mar 7;26(3):917-931
pubmed: 29433935
N Engl J Med. 2020 May 7;382(19):1811-1822
pubmed: 32374962
Clin Immunol. 2013 Jun;147(3):155-74
pubmed: 23711932
Clin Infect Dis. 2004 Sep 1;39(5):692-9
pubmed: 15356785
Sci Transl Med. 2016 Apr 20;8(335):335ra57
pubmed: 27099176
J Clin Immunol. 2008 Sep;28(5):581-7
pubmed: 18481161
Front Immunol. 2018 Mar 16;9:543
pubmed: 29599784
J Allergy Clin Immunol. 2018 Nov;142(5):1665-1669
pubmed: 30092289
Dermatologica. 1946;92(1):30-43
pubmed: 20982046
J Exp Med. 2011 Aug 1;208(8):1635-48
pubmed: 21727188
Semin Immunol. 2014 Dec;26(6):454-70
pubmed: 25453225
Nat Med. 2020 Sep;26(9):1392-1397
pubmed: 32778825
Bull World Health Organ. 2008 Apr;86(4):317-9
pubmed: 18438522
Front Immunol. 2020 Mar 17;11:455
pubmed: 32256498
J Allergy Clin Immunol. 2015 Feb;135(2):551-3
pubmed: 25662309
Curr Opin Immunol. 2017 Oct;48:122-133
pubmed: 28992464
N Engl J Med. 2014 Jul 31;371(5):434-46
pubmed: 25075835
NPJ Genom Med. 2018 Apr 4;3:10
pubmed: 29644095
PLoS One. 2009;4(4):e5321
pubmed: 19390687
N Engl J Med. 2019 Apr 18;380(16):1525-1534
pubmed: 30995372
Nat Immunol. 2016 May;17(5):495-504
pubmed: 27019227
J Clin Immunol. 2007 Sep;27(5):497-502
pubmed: 17577648
CMAJ. 2018 Apr 9;190(14):E422-E429
pubmed: 29632037
Front Immunol. 2019 Dec 20;10:2940
pubmed: 31921190
Pediatrics. 2017 Feb;139(2):
pubmed: 28096516
Nat Med. 2019 Dec;25(12):1813-1814
pubmed: 31768067
Blood. 2013 May 9;121(19):3830-7, S1-7
pubmed: 23502222
Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16463-16472
pubmed: 31346092
Blood. 2010 Sep 30;116(13):2229-36
pubmed: 20530285
J Clin Immunol. 2014 Nov;34(8):954-61
pubmed: 25257253
Hum Gene Ther. 2016 Feb;27(2):108-16
pubmed: 26790362
Clin Immunol. 2017 Jul;180:106-110
pubmed: 28487086
J Proteomics. 2015 Aug 3;126:155-62
pubmed: 26047714
Genet Med. 2020 Apr;22(4):809-810
pubmed: 31767983
Front Immunol. 2018 Sep 19;9:2078
pubmed: 30283440
Blood. 2016 Jan 7;127(1):17-28
pubmed: 26504182
Bol Oficina Sanit Panam. 1968 Oct;65(4):281-393
pubmed: 4234760
J Clin Invest. 2019 Feb 1;129(2):583-597
pubmed: 30422821
Ann Paediatr. 1950 Jul-Aug;175(1-2):1-32
pubmed: 15433018
J Allergy Clin Immunol. 2014 Jul;134(1):226-8
pubmed: 24882743
Cent Eur J Immunol. 2017;42(4):336-341
pubmed: 29479289
J Clin Immunol. 2018 Jan;38(1):56-66
pubmed: 29116556
N Engl J Med. 2007 Oct 18;357(16):1608-19
pubmed: 17881745
Blood. 2011 Mar 17;117(11):3243-6
pubmed: 21273302
Science. 2015 Jul 24;349(6246):436-40
pubmed: 26206937
J Pediatric Infect Dis Soc. 2018 Dec 26;7(suppl_2):S79-S82
pubmed: 30590619
Genet Med. 2012 Jan;14(1):129-34
pubmed: 22237442
F1000Res. 2020 Mar 19;9:
pubmed: 32226610
Pediatrics. 1952 Jun;9(6):722-8
pubmed: 14929630
Nat Genet. 2003 Mar;33(3):388-91
pubmed: 12590259
NPJ Genom Med. 2020 Sep 4;5:36
pubmed: 32944285
J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1958-1969.e9
pubmed: 30825606
Clin Exp Immunol. 2020 May;200(2):176-184
pubmed: 31989577
Blood. 2015 Jan 22;125(4):591-9
pubmed: 25359994
World Allergy Organ J. 2019 Mar 22;12(3):100018
pubmed: 30937141
J Allergy Clin Immunol. 2019 Mar;143(3):852-863
pubmed: 30194989
Genes Dis. 2019 Jul 30;7(1):38-51
pubmed: 32181274
Blood. 2018 Feb 22;131(8):917-931
pubmed: 29279357
Nature. 1993 Jan 21;361(6409):226-33
pubmed: 8380905
Genet Med. 2017 Dec;19(12):1367-1375
pubmed: 28617419
Pediatr Allergy Immunol. 2018 Jun;29(4):453-456
pubmed: 29543351
Acta Paediatr Suppl (Upps). 1956 Feb;45(Suppl 105):1-78
pubmed: 13326376
J Pediatr. 2005 Aug;147(2):256-9
pubmed: 16126062
N Engl J Med. 1987 Mar 5;316(10):589-96
pubmed: 3807953

Auteurs

Jovanka R King (JR)

Department of Clinical Immunology, Karolinska University Hospital Huddinge, Stockholm, Sweden; Department of Immunopathology, SA Pathology, Women's and Children's Hospital Campus, Adelaide, Australia; Robinson Research Institute and Discipline of Paediatrics, School of Medicine, University of Adelaide, Adelaide, Australia.

Luigi D Notarangelo (LD)

Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.

Lennart Hammarström (L)

Department of Clinical Immunology, Karolinska University Hospital Huddinge, Stockholm, Sweden. Electronic address: lennart.hammarstrom@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH